PRE 14A

OXIGENE, INC.

Company: Oncotelic Therapeutics, Inc.
Filed: May 19, 2010
Period of Report: May 19, 2010
Accession Number: 0000950123-10-051315

View Document ↗ View on SEC.gov ↗